Related Experiment Videos
Postoperative mediastinitis due to Finegoldia magna with negative blood cultures
Solen Kernéis1, Matta Matta, Annie Buu Hoï
1AP-HP, Hôpital Européen Georges Pompidou, Service de Microbiologie, Paris, France. solen.kerneis@cch.aphp.fr
Abstract:
We report a case of Finegoldia magna (formerly known as Peptostreptococcus magnus) mediastinitis following coronary artery bypass in a 50-year-old patient. Even if staphylococci remain the main causative organism of postoperative mediastinitis, the responsibility of anaerobic bacteria must be considered in cases of fever and sternal drainage with negative blood cultures.
Insights
Finegoldia magna, a type of anaerobic bacteria, can cause mediastinitis after heart surgery. This case highlights the importance of considering anaerobic bacteria in postoperative infections, even with negative blood cultures.
Area of Science:
- Infectious Diseases
- Cardiovascular Surgery
- Microbiology
Background:
- Postoperative mediastinitis is a serious complication following cardiac surgery.
- Staphylococci are the most common pathogens implicated in these infections.
Observation:
- A 50-year-old patient developed mediastinitis after coronary artery bypass surgery.
- The patient presented with fever and sternal drainage.
Findings:
- Blood cultures were negative, but Finegoldia magna (formerly Peptostreptococcus magnus), an anaerobic bacterium, was identified as the causative agent.
- This case underscores the role of anaerobic bacteria in postoperative mediastinitis.
Implications:
- Clinicians should consider anaerobic bacteria in the differential diagnosis of postoperative mediastinitis, especially when initial blood cultures are negative.
- Prompt identification and appropriate antibiotic therapy are crucial for managing such infections.
- This finding may influence diagnostic strategies and treatment protocols for post-cardiac surgery infections.
Related Concept Videos
Endocarditis III: Medical Management
Aneurysm IV: Nursing Management
Mitral Stenosis III: Medical Management
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations: